A critical review of the antipsychotic effects of cannabidiol: 30 years of a translational investigation (2012)
- Authors:
- USP affiliated authors: CRIPPA, JOSÉ ALEXANDRE DE SOUZA - FMRP ; ZUARDI, ANTONIO WALDO - FMRP ; HALLAK, JAIME EDUARDO CECILIO - FMRP ; GUIMARÃES, FRANCISCO SILVEIRA - FMRP
- Unidade: FMRP
- DOI: 10.2174/138161212802884681
- Subjects: CANNABIS; ANTIPSICÓTICOS; TRANSTORNOS PSICÓTICOS
- Language: Inglês
- Imprenta:
- Source:
- Título: Current Phamaceutical Design
- ISSN: 1873-4286
- Volume/Número/Paginação/Ano: v. 18, n. 32, p. 5131-5140, 2012
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
ZUARDI, Antonio Waldo et al. A critical review of the antipsychotic effects of cannabidiol: 30 years of a translational investigation. Current Phamaceutical Design, v. 18, n. 32, p. 5131-5140, 2012Tradução . . Disponível em: https://doi.org/10.2174/138161212802884681. Acesso em: 12 fev. 2026. -
APA
Zuardi, A. W., Crippa, J. A. de S., Hallak, J. E. C., Bhattacharyya, S., Atakan, Z., Martín-Santos, R., et al. (2012). A critical review of the antipsychotic effects of cannabidiol: 30 years of a translational investigation. Current Phamaceutical Design, 18( 32), 5131-5140. doi:10.2174/138161212802884681 -
NLM
Zuardi AW, Crippa JA de S, Hallak JEC, Bhattacharyya S, Atakan Z, Martín-Santos R, McGuire PK, Guimarães FS. A critical review of the antipsychotic effects of cannabidiol: 30 years of a translational investigation [Internet]. Current Phamaceutical Design. 2012 ; 18( 32): 5131-5140.[citado 2026 fev. 12 ] Available from: https://doi.org/10.2174/138161212802884681 -
Vancouver
Zuardi AW, Crippa JA de S, Hallak JEC, Bhattacharyya S, Atakan Z, Martín-Santos R, McGuire PK, Guimarães FS. A critical review of the antipsychotic effects of cannabidiol: 30 years of a translational investigation [Internet]. Current Phamaceutical Design. 2012 ; 18( 32): 5131-5140.[citado 2026 fev. 12 ] Available from: https://doi.org/10.2174/138161212802884681 - Is the highest density of CB1 receptors in paranoid schizophrenia a correlate of endocannabinoid system functioning?
- Effects of minocycline on regional cerebral blood flow in schizophrenia
- Canabidiol: possíveis aplicacões terapêuticas em psicopatologias
- Cannabidiol, a cannabis sativa constituent, as an antipsycholic drug
- Possible therapeutic uses of cannabidiol in anxiety disorders and schizophrenia
- Effects of cannabidiol on symptoms induced by the recall of traumatic events in patients with posttraumatic stress disorder
- Dr. Raphael Mechoulam, cannabis and cannabinoids research pioneer (November 5, 1930-March 9, 2023) and his legacy for Brazilian pharmacology [Editorial]
- Cannabidiol and neuroprotection: evidence from preclinical studies
- Cannabidiol displays proteomic similarities to antipsychotics in cuprizone-exposed human oligodendrocytic cell line MO3.13
- Marijuana, feijoada and the debate on drug legalization
Informações sobre o DOI: 10.2174/138161212802884681 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
